| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Technology Officer | Stock Option (right to buy) | 300,000 | 09 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 09 Feb 2026 | 0 | $0 | 3 | Chief Technology Officer | 11 Feb 2026, 16:30 |
| KYTX | Kyverna Therapeutics, Inc. | 09 Feb 2026 | 1 | $0 | 4 | Chief Technology Officer | 11 Feb 2026, 16:30 |